Story perspectives
US Tariffs on Drugs Risk $750M Healthcare Crisis
5/21/2025
36 7
1 of 1
Story summary
- US tariffs on pharmaceuticals and medical supplies threaten to escalate healthcare costs and limit access for patients. A staggering 25% tariff on Canadian drugs could inflate US drug prices by $750 million, putting immense pressure on hospitals already grappling with financial strain and potential shortages. Immediate policy intervention is crucial to avert a healthcare crisis.
